Related Experiment Videos
Relationship between imidazoline(2) sites and monoamine oxidase
L M Paterson1, R J Tyacke, D J Nutt
1Psychopharmacology Unit, School of Medical Sciences, University of Bristol, Bristol BS8 1TD, UK.
Annals of the New York Academy of Sciences
|March 19, 2004
Summary
Selective I(2) site compounds interact with monoamine oxidase (MAO). Irreversible binding of BU99006 to I(2) sites did not inhibit MAO, suggesting distinct I(2) binding proteins and clarifying the MAO-I(2) relationship.
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- I(2) site-selective compounds are known to interact with and inhibit monoamine oxidase (MAO).
- The precise nature of this interaction (allosteric or competitive) remains unclear.
- Distinguishing between MAO and I(2) binding sites is crucial for understanding their functional relationship.
Purpose of the Study:
- To clarify the relationship between monoamine oxidase (MAO) and I(2) binding sites (I(2)-BS).
- To investigate whether I(2) binding sites are directly involved in MAO inhibition.
- To determine if the I(2) ligand BU99006 interacts with MAO.
Main Methods:
- Utilized a new selective, irreversible I(2) ligand, BU99006.
- Administered BU99006 to rat brain membranes.
- Assessed the effect of BU99006 binding on MAO enzyme activity.
- Evaluated the interference of BU99006 with other imidazoline enzyme inhibitors.
Main Results:
- Irreversible binding of BU99006 to rat brain membranes did not inhibit MAO enzyme activity.
- BU99006 binding did not interfere with the interaction of other imidazoline enzyme inhibitors.
- These findings indicate that the I(2) sites binding BU99006 are distinct from those involved in MAO inhibition.
Conclusions:
- The I(2) binding sites that react with BU99006 are not implicated in MAO inhibition.
- This suggests the existence of at least two distinct I(2) binding proteins.
- The study differentiates between MAO and specific I(2) binding proteins, advancing the understanding of their interactions.